Literature DB >> 2376950

Psychopathological and neuropsychological symptoms in patients with subclinical and remitted hyperthyroidism.

M Bommer1, T Eversmann, R Pickardt, A Leonhardt, D Naber.   

Abstract

To investigate relationships between hyperthyroidism and behavior, 45 formerly hyperthyroid patients (now euthyroid) and 51 control subjects were investigated by (a) a semi-structured psychiatric examination, (b) self-rating scales to assess mood states and personality, and (c) neuropsychological tests. Patients with "subclinical" or "remitted" hyperthyroidism showed more abnormalities than the controls in all dimensions investigated. Forty-three percent of patients (10% of controls) complained of "seriously reduced" well-being with feelings of fear, hostility, and inability to concentrate. While a fearful-agitated syndrome dominated in the initial phase of the illness, a mainly depressive syndrome was characteristic after a longer period of remission. More than 25% of the patients (2% of controls) showed "markedly impaired" neuropsychological functioning. Patients with a relapse within 2.5 years exhibited the most abnormal results. Even after a longer period of hormonal remission, there was no complete psychopathological and neuropsychological normalization. A thorough follow-up of hyperthyroid patients is recommended.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2376950     DOI: 10.1007/bf01667147

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

1.  Psychophysiology and psychiatric management of thyrotoxicosis: a two year follow-up study.

Authors:  H J KLEINSCHMIDT; S E WAXENBERG; R CUKER
Journal:  J Mt Sinai Hosp N Y       Date:  1956 Mar-Apr

2.  Investigation of the validity of Halstead's measures of biological intelligence.

Authors:  R M REITAN
Journal:  AMA Arch Neurol Psychiatry       Date:  1955-01

3.  Hormones of the hypothalamic-pituitary-thyroid axis: a psychoneuroendocrine perspective.

Authors:  P T Loosen
Journal:  Pharmacopsychiatry       Date:  1986-11       Impact factor: 5.788

4.  Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement.

Authors:  P C Whybrow; A J Prange; C R Treadway
Journal:  Arch Gen Psychiatry       Date:  1969-01

5.  The Trail Making Test in neuropsychological diagnosis.

Authors:  N G Gordon
Journal:  J Clin Psychol       Date:  1972-04

6.  A psychiatric and neuropsychological study of patients with untreated Graves' disease.

Authors:  P T Trzepacz; M McCue; I Klein; G S Levey; J Greenhouse
Journal:  Gen Hosp Psychiatry       Date:  1988-01       Impact factor: 3.238

7.  [The multiple selection vocabulary test (MSVT-B)--an accelerated intelligence test].

Authors:  J Merz; S Lehrl; V Galster; H Erzigkeit
Journal:  Psychiatr Neurol Med Psychol (Leipz)       Date:  1975-07

8.  Emotional disturbance and cognitive deficits in hyperthyroidism.

Authors:  D J MacCrimmon; J E Wallace; W M Goldberg; D L Streiner
Journal:  Psychosom Med       Date:  1979-06       Impact factor: 4.312

9.  Depression in thyrotoxicosis.

Authors:  J W Taylor
Journal:  Am J Psychiatry       Date:  1975-05       Impact factor: 18.112

10.  Cerebral function in hyperthyroid patients. Psychopathology, psychometric variables, central arousal and time perception before and after thyreostatic therapy.

Authors:  J Zeitlhofer; B Saletu; J Stary; R Ahmadi
Journal:  Neuropsychobiology       Date:  1984       Impact factor: 2.328

View more
  11 in total

Review 1.  Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.

Authors:  Robertas Bunevicius; Arthur J Prange
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 2.  Hormones and cognition: current concepts and issues in neuropsychology.

Authors:  D M Erlanger; K C Kutner; A R Jacobs
Journal:  Neuropsychol Rev       Date:  1999-12       Impact factor: 7.444

3.  Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Thyroid       Date:  2019-05-13       Impact factor: 6.568

4.  Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Circulation       Date:  2019-05-13       Impact factor: 29.690

5.  Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis.

Authors:  M H Samuels; K G Schuff; N E Carlson; P Carello; J S Janowsky
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

6.  The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition.

Authors:  Mary H Samuels; Irina Kolobova; Anne Smeraglio; Dawn Peters; Jeri S Janowsky; Kathryn G Schuff
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958

7.  Health-related quality of life in patients with thyroid disorders.

Authors:  G P Bianchi; V Zaccheroni; E Solaroli; F Vescini; R Cerutti; M Zoli; G Marchesini
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

8.  Subclinical hyperthyroidism: physical and mental state of patients.

Authors:  B Schlote; B Nowotny; L Schaaf; D Kleinböhl; R Schmidt; J Teuber; R Paschke; I Vardarli; S Kaumeier; K H Usadel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

9.  The thyroid function of Graves' disease patients is aggravated by depressive personality during antithyroid drug treatment.

Authors:  Atsushi Fukao; Junta Takamatsu; Sumihisa Kubota; Akira Miyauchi; Toshiaki Hanafusa
Journal:  Biopsychosoc Med       Date:  2011-08-09

10.  Anxiety and depression are more prevalent in patients with graves' disease than in patients with nodular goitre.

Authors:  Kira Bang Bové; Torquil Watt; Asmus Vogel; Laszlo Hegedüs; Jakob Bue Bjoerner; Mogens Groenvold; Steen Joop Bonnema; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen
Journal:  Eur Thyroid J       Date:  2014-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.